We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $14.1B
1-Year Est. Return 30.11%
This Fund
S&P 500
This Quarter Est. Return
+10.78%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$12.6B
AUM Growth
+$661M
Cap. Flow
-$336M
Cap. Flow %
-2.66%
Top 10 Hldgs %
41.35%
Holding
1,574
New
66
Increased
677
Reduced
765
Closed
48

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$29.1M
2
NVDA icon
NVIDIA
NVDA
+$28M
3
AMZN icon
Amazon
AMZN
+$26M
4
META icon
Meta Platforms (Facebook)
META
+$25.6M
5
MSFT icon
Microsoft
MSFT
+$24M

Sector Composition

Rank Sector Weight
1 Technology 39.01%
2 Financials 11.35%
3 Consumer Discretionary 11.29%
4 Communication Services 10.59%
5 Healthcare 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RZLV
1476
Rezolve AI
RZLV
$917M
$57.3K ﹤0.01%
+11,505
New +$45.3K
LFST icon
1477
Lifestance Health
LFST
$4.13B
$57.2K ﹤0.01%
10,399
+130
+1% +$637
AMBP icon
1478
Ardagh Metal Packaging
AMBP
$2.82B
$57K ﹤0.01%
14,274
+5
+0% +$20
BDN
1479
Brandywine Realty Trust
BDN
$533M
$56K ﹤0.01%
13,420
+124
+0.9% +$521
GGB icon
1480
Gerdau
GGB
$9.36B
$54.9K ﹤0.01%
17,725
+3,230
+22% +$9.77K
BRSP
1481
BrightSpire Capital
BRSP
$679M
$54.5K ﹤0.01%
+10,039
New +$54.6K
TSHA icon
1482
Taysha Gene Therapies
TSHA
$1.68B
$54.2K ﹤0.01%
16,575
+3,738
+29% +$10.6K
RLAY icon
1483
Relay Therapeutics
RLAY
$4.16B
$54K ﹤0.01%
10,336
+63
+0.6% +$240
ABUS icon
1484
Arbutus Biopharma
ABUS
$883M
$53.6K ﹤0.01%
11,796
+174
+1% +$639
AKBA icon
1485
Akebia Therapeutics
AKBA
$327M
$53.4K ﹤0.01%
19,546
+217
+1% +$722
SABR icon
1486
Sabre
SABR
$668M
$52K ﹤0.01%
28,425
BORR
1487
Borr Drilling
BORR
$1.31B
$51.9K ﹤0.01%
19,301
+2,067
+12% +$5.14K
RC
1488
Ready Capital
RC
$267M
$50.6K ﹤0.01%
13,082
+134
+1% +$565
NAT icon
1489
Nordic American Tanker
NAT
$1.36B
$50.2K ﹤0.01%
16,003
+136
+0.9% +$401
OPK icon
1490
Opko Health
OPK
$883M
$49.9K ﹤0.01%
32,170
+4,221
+15% +$5.8K
TDAY
1491
USA Today Co
TDAY
$1.22B
$49.2K ﹤0.01%
11,921
+59
+0.5% +$237
OPTU
1492
Optimum Communications Inc
OPTU
$340M
$49.1K ﹤0.01%
20,376
+294
+1% +$721
CIG icon
1493
CEMIG Preferred Shares
CIG
$6.21B
$46.1K ﹤0.01%
21,869
+2,610
+14% +$5.12K
EU
1494
enCore Energy
EU
$235M
$46.1K ﹤0.01%
14,359
+144
+1% +$388
IOVA icon
1495
Iovance Biotherapeutics
IOVA
$2.29B
$44.1K ﹤0.01%
20,338
+398
+2% +$940
IBRX icon
1496
ImmunityBio
IBRX
$7.75B
$44K ﹤0.01%
17,898
+112
+0.6% +$288
ESPR
1497
DELISTED
Esperion Therapeutics
ESPR
$41.3K ﹤0.01%
15,588
+117
+0.8% +$226
SLDP icon
1498
Solid Power
SLDP
$484M
$41K ﹤0.01%
11,807
+513
+5% +$1.93K
ABEV icon
1499
Ambev
ABEV
$47.7B
$40.4K ﹤0.01%
18,115
+1,817
+11% +$4.16K
GOSS icon
1500
Gossamer Bio
GOSS
$69.7M
$39K ﹤0.01%
14,822
+145
+1% +$320

Similar funds

Xponance's Q3 2025 Portfolio in Review

As of Q3 2025, Xponance held 1,574 positions worth $12.6B, up 5.5% from $12B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Xponance's Q3 2025 filing shows 66 new, 677 increased, 765 reduced and 48 closed positions. Its largest new stake was State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF: 138,610 shares worth $7.6M. The largest sale was Apple, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 37% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Xponance's largest Q3 2025 buy was State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF: 138,610 shares worth $7.6M.
  • Xponance added most to DuPont de Nemours in Q3 2025, an estimated $5.38M increase.
  • Xponance's biggest Q3 2025 reduction was Apple, cutting an estimated $29.1M.
  • Xponance fully exited iShares MSCI World ETF in Q3 2025, selling an estimated $9.91M.
  • Xponance's ten largest holdings make up 41% of its $12.6B portfolio in Q3 2025.
  • Xponance opened 66 new positions and closed 48 in Q3 2025.
  • Xponance's portfolio value rose 5.5% quarter-over-quarter to $12.6B.

Based on Xponance's 13F filing for Q3 2025, filed 12 Nov 2025.